Method for treating a GD2 positive cancer
- Resource Type
- Patent
- Authors
- Source
- Subject
- Language
The present invention relates to a method for treating a GD2 positive cancer by administering a preparation comprising an anti-GD2 antibody to a patient as a continuous intravenous infusion over 24 hours per day.